GRCE

Grace Therapeutics
GRCE

Overview Fund Trends Analyst Outlook Journalist POV

7 hedge funds and large institutions have $479K invested in Grace Therapeutics in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$55K

Top Sellers

1
-$527K
2
-$117K
3
-$23K
4
Citadel Advisors
Citadel Advisors
Florida
-$19K
5
UBS Group
UBS Group
Switzerland
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$199K
2
$81K
3
$79K
4
$63K
5
$52K
6
$5K
7
$39
8
–
9
–
10
–
11
–
12
–